Ashwin C. Parenky
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
Papers in
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- T-cell and B-cell Immunology 1
-
- Protein purification and stability 3
- Protein Interaction Studies and Fluorescence Analysis 1
- Co-authors
- Ripal Gaudana (3 shared papers)Ashim K. Mitra (2 shared papers)Hari Krishna Ananthula (1 shared paper)Varun Khurana (1 shared paper)Ashim K. Mitra (1 shared paper)Valerie Quarmby (1 shared paper)Heather Myler (1 shared paper)Amy S. Rosenberg (1 shared paper)
- Journals
- The AAPS Journal (2 papers)Vaccines (1 paper)Pharmaceuticals (1 paper)Journal of Microencapsulation (1 paper)AAPS PharmSciTech (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Ashwin C. Parenky
9 papers receiving 1.1k citations
Ashwin C. Parenky's Hit Papers
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 523
- Ophthalmology 275
- Public Health, Environmental and Occupational Health 437
- Radiology, Nuclear Medicine and Imaging 260
- Biomaterials 122
Countries citing papers authored by Ashwin C. Parenky
This map shows the geographic impact of Ashwin C. Parenky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin C. Parenky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin C. Parenky more than expected).
Fields of papers citing papers by Ashwin C. Parenky
This network shows the impact of papers produced by Ashwin C. Parenky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin C. Parenky. The network helps show where Ashwin C. Parenky may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashwin C. Parenky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ocular Drug Delivery Hit paper breakdown → | 2010 | 1021 |
| 2 | 2014 | 40 | |
| 3 | 2011 | 27 | |
| 4 | 2010 | 22 | |
| 5 | 2021 | 19 | |
| 6 | 2019 | 15 | |
| 7 | 2022 | 3 | |
| 8 | 2025 | 3 | |
| 9 | 2023 | 2 |
About Ashwin C. Parenky
Ashwin C. Parenky is a scholar working on Immunology, Molecular Biology, Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging and Ophthalmology, having authored 9 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers), Advanced Drug Delivery Systems (3 papers), Immune Cell Function and Interaction (2 papers), Retinal Diseases and Treatments (1 paper), Corneal Surgery and Treatments (1 paper), Protein Interaction Studies and Fluorescence Analysis (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Pharmaceutical Science (523 citations), Ophthalmology (275 citations), Public Health, Environmental and Occupational Health (437 citations), Radiology, Nuclear Medicine and Imaging (260 citations) and Biomaterials (122 citations). Ashwin C. Parenky has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Ripal Gaudana, Ashim K. Mitra, Hari Krishna Ananthula, Varun Khurana, Ashim K. Mitra, Valerie Quarmby, Heather Myler, Amy S. Rosenberg, Susan Kirshner and Karoline Bechtold-Peters. Their work appears in journals such as The AAPS Journal, Vaccines, Pharmaceuticals, Journal of Microencapsulation and AAPS PharmSciTech.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.